4-(2-Bromoethyl)morpholine

Ref. 3D-FB139679

Informations sur le produit

• Nom: 4-(2-Bromoethyl)morpholine
• Marque: Biosynth
• Description: 4-(2-Bromoethyl)morpholine is a potential anticancer agent that has been found to inhibit the viability of human cancer cells in vitro. It is believed to be an anticancer drug because it binds to the CB2 receptor and inhibits the production of collagen, which is needed for tumor growth. 4-(2-Bromoethyl)morpholine has been shown to inhibit platelet aggregation and reduce blood viscosity, making it a possible treatment for coronary heart disease. It also inhibits the release of nitric oxide, which can lead to atherosclerosis. 4-(2-Bromoethyl)morpholine has been synthesized by reacting methylamine with morpholine in the presence of nitrogen gas at high temperature and pressure. This reaction produces a gaseous product that is then condensed into nanocarriers that are soluble in water. The acidic nature of this compound may introduce imidazole derivatives as prodrugs for its activity.

Propriétés chimiques

• Masse moléculaire: 194.07 g/mol
• Formule: C₆H₁₂BrNO
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C6H12BrNO/c7-1-2-8-3-5-9-6-4-8/h1-6H2
• Code InChI: InChIKey=CVMXEDZZSWLXPB-UHFFFAOYSA-N
• SMILES: BrCCN1CCOCC1